Genetic aspects of chronic pancreatitis: Insights into aetiopathogenesis and clinical implications

Swiss Medical Weekly

Volumn 131, Issue 39-40, 2001, Pages 565-574

  Truninger, K ^a   Ammann, R W ^a   Blum, H E ^a   Witt, H ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chronic pancreatitis; SPINK1; Trypsin

Indexed keywords

APROTININ; ENZYME PRECURSOR; PANCREAS ENZYME; PROTEINASE; PROTEINASE INHIBITOR; TRYPSIN; TRYPSINOGEN;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL INHERITANCE; CHRONIC PANCREATITIS; ENZYME INHIBITION; FAMILY HISTORY; GENE MUTATION; HEREDITY; HUMAN; PATHOGENESIS; REVIEW; RISK FACTOR;

EID: 0035818345     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. The natural history of pain in alcoholic chronic pancreatitis
2. Pathology of acute and chronic pancreatitis
3. Chronic pancreatitis: Diagnosis, classification, and new genetic developments
4. Prognosis of chronic pancreatitis, an international multicenter study
5. A clinically based classification system for alcoholic chronic pancreatitis: Summary of an international workshop on chronic pancreatitis
6. Acute pancreatitis
7. Chronic pancreatitis
8. Natural history of chronic pancreatitis
9. Chronic pancreatitis: Still puzzling?
10. Experimental pancreatitis
11. Treatment of acute pancreatitis. Comparison of animal and human studies
12. The pathophysiology of alcoholic pancreatitis
13. Definitions and classifications of pancreatitis
14. Chronic relapsing pancreatitis: A study of 29 cases without associated diseases of the biliary or gastro-intestinal tract
15. Course of alcoholic chronic pancreatitis: A prospective clinicomorphological long-term study
16. A framework for the etiopathogenesis of chronic pancreatitis
17. Division of the sphincter of Oddi for treatment of dysfunction associated with recurrent pancreatitis
18. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis
19. Progression of alcoholic acute to chronic pancreatitis
20. Ueber die selbstverdauung des menschlichen pankreas
21. Early trypsinogen activation in acute pancreatitis
22. Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, and protective mechanisms against inappropriate activation
23. Pancreatic secretory enzymes
24. A family of 16kDa pancreatic secretory stress proteins form highly organized fibrillar structures upon tryptic activation
25. Pedigree of a family with hereditary chronic relapsing pancreatitis
26. Hereditary pancreatitis
27. Genetic predisposition to acute and chronic pancreatitis
28. Long-term follow-up of young patients with chronic hereditary or idiopathic pancreatitis
29. Hereditary pancreatitis and the risk of pancreatic cancer
30. Idiopathic "juvenile" chronic pancreatitis
31. Die «senile» chronische pankreatitis - eine neue nosologische einheit?
32. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis
33. Individual susceptibility to alcoholic pancreatitis: Still an enigma
34. Chonic pancreatitis
35. The hereditary pancreatitis gene maps to long arm of chromosome 7
36. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cm region on 7q
37. A gene for hereditary pancreatitis maps to chromosome 7q35
38. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus
39. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
40. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis
41. Mutations of the cationic trypsinogen in hereditary pancreatitis
42. Mutations of the cationic trypsinogen gene in patients with hereditary pancreatitis
43. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis
44. Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis
45. Trypsinogen gene mutations in patients with chronic or recurrent acute pancreatitis
46. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis
47. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis
48. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation
49. Heterogeneity in hereditary pancreatitis
50. Exclusion of anionic trypsinogen and mesotrypsinogen involvement in hereditary pancreatitis without cationic trypsinogen gene mutations
51. The pancreatitis-associated protein in hereditary and chronic alcoholic pancreatitis
52. A new hereditary pancreatitis gene may map to chromosome 12
53. Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins
54. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis
55. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis
56. Screening for mutations of the cationic trypsinogen gene: Are they of relevance in chronic alcoholic pancreatitis?
57. Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh
58. The identification of neotrypsinogens in samples of bovine trypsinogen
59. Limited proteolysis in pancreatic chymotrypsinogens and trypsinogens
60. Crystal structure of human trypsin 1: Unexpected phosphorylation of Tyr151
61. Hereditary pancreatitis-associated mutation asn(21) → ile stabilizes rat trypsinogen in vitro
62. Two mutations in rat trypsin confer resistance against autolysis
63. Monoclonal antibodies to human pancreatic trypsin 1 inhibit the activation of human trypsinogens 1 and 2
64. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen
65. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis
66. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis
67. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis
68. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis
69. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis
70. Chronic pancreatitis
71. SPINK1 mutations in chronic pancreatitis
72. SPINK1 mutations in chronic pancreatitis
73. The liver in adolescents with alpha 1-antitrypsin deficiency
74. The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein
75. Cystic fibrosis
76. Sweat electrolytes in chronic pancreatitis
77. Pathology and pathogenesis of diseases of the pancreas
78. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
79. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
80. Increased prevalence of mutations of the cystic fibrosis gene in idiopathic chronic and recurrent pancreatitis
81. Pancreatitis and cystic fibrosis gene mutations
82. Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes
83. Pancreatic aspects of CF and other inherited causes of pancreatic dysfunction
84. Cystic fibrosis
85. Mechanisms to explain pancreatic dysfunction in cystic fibrosis
86. Cystic fibrosis genotypes and alcoholic pancreatitis
87. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
88. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases
89. Mutations of the serine protease inhibitor, Kazal type 1 in patients with idiopatic chronic pancreatitis